about
Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.Cerebrospinal fluid and blood biomarkers in Alzheimer's diseaseBiomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomicsBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseTotal and phosphorylated tau protein as biological markers of Alzheimer's disease.Quantitative structural MRI for early detection of Alzheimer's disease.Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy.Confounding factors influencing amyloid Beta concentration in cerebrospinal fluidA biomarker for severity of Alzheimer's disease: 1H-NMR resonances in cerebrospinal fluid correlate with performance in mini-mental-state-exam.Biomarkers of Alzheimer's disease risk in peripheral tissues; focus on buccal cells.Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.The influence of cerebrospinal fluid (CSF) biomarkers on clinical dementia evaluationsBrain biopsy in neurologic decline of unknown etiology.Impact of early intervention and disease modification in patients with predementia Alzheimer's disease: a Markov model simulation.Cerebrospinal Fluid Biomarkers of Japanese EncephalitisContributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's diseaseCognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer's Disease Neuroimaging Initiative).Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation.Plasma proteomics for the identification of Alzheimer disease.Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluidsDetection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers.Cerebrospinal fluid aβ to tau ratio and postoperative cognitive changeCombined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer DiseaseEffects of anesthetic isoflurane and desflurane on human cerebrospinal fluid Aβ and τ level.Role of progranulin as a biomarker for Alzheimer's disease.Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis.Intranetwork and internetwork connectivity in patients with Alzheimer disease and the association with cerebrospinal fluid biomarker levels.Broadband Infrared Spectroscopy for Non-Contact Measurement of Neurological Disease Biomarkers in Cerebrospinal Fluid.The p75NTR extracellular domain: a potential molecule regulating the solubility and removal of amyloid-β.Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia.Detailed analysis of the supermarket task included on the Japanese version of the Rapid Dementia Screening Test.Systemic Inflammation and Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and Alzheimer's Disease.Correlations between mini-mental state examination score, cerebrospinal fluid biomarkers, and pathology observed in brain biopsies of patients with normal-pressure hydrocephalus.Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents.Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease.Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers.Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation Abilities.Diagnosis of neurodegenerative dementia: where do we stand, now?Derivation of cutoffs for the Elecsys® amyloid β (1–42) assay in Alzheimer's diseaseCognitive Reserve Relates to Functional Network Efficiency in Alzheimer's Disease
P2860
Q26858963-31FCD6D3-3746-4135-8F7A-DD063F2DB8B3Q27023758-2F4CBCA5-F5D1-4BC3-9216-11043C0909FEQ27024518-BD44A003-92E6-4B7E-979F-118B8C33EE0EQ28259585-7B31AC5D-AB8A-4871-88FF-716329C045FEQ33624674-06EF8E25-9618-4B6C-871B-2A7BF4FE3E4CQ33729033-EA0C118A-FDDA-46A2-8B4D-71FBA30851B0Q33737141-E175C988-60F0-46BB-96F0-F5AE77C1A3C8Q34078408-9F786C7C-C0FA-4D74-9704-6A95A9629944Q34144542-B78346AC-5AA5-4FA5-B014-E408770B5E29Q34201730-1ACCF32C-DFD5-415F-81D0-CFA238929586Q34250065-E1E71C7F-F6F0-4742-9F57-E46FEECF9CBFQ34873817-C54BBE15-2C67-4DE9-978A-C85211E54840Q35236240-1DD814FC-ED01-4B8C-B029-5F089569F6D7Q35454453-DBD8852D-FF02-4A42-A925-BBC8687669AFQ35953808-1C456D59-114F-40DB-9405-91AC6A7A7215Q35997824-1CE53CBC-451E-4B44-8D2B-4838CD499A8FQ36160452-782EA9AE-46AB-419B-BE1F-12D1B3AD392BQ36651546-D5FAB368-D2C2-4881-9955-77BDCF3DFF5FQ36767124-01393C31-D0AA-4525-BFF0-06B3FBB05F38Q36889137-4553C5F5-F493-4A9D-BB4A-60A9295A9E6BQ36934163-AF6A8513-55F4-4D94-AF3D-8909B5A334EDQ37430671-49227D92-B7B2-4B78-A02B-79A4927FEA5BQ37559815-BCEB7F8C-4E5B-4C80-BD52-6E8E1897E352Q37609473-9D81FFE8-B7EA-4174-8FC6-E7F6279884B2Q37730008-0F10F7D3-3113-427B-8A44-08E083479163Q38719589-07978E03-2CC9-4785-88CE-7165388E097EQ38856483-B00173B7-D6A5-4476-A5B8-0EEF6790D983Q39383233-54285747-2FF9-41AB-A30F-E5C97F1BA6D0Q39439973-74B237FB-F648-4047-88BF-57B1E3A8C6CCQ39491442-47041069-F63C-48FF-84A3-2B1F90CC3879Q40675384-048FCE08-0581-49D7-A16A-B4AE793EF3F1Q47642585-C575FC97-C1F1-4217-8F27-5B92127D812DQ48232658-DCF1320F-1E59-4714-9B78-4D4146FD1E13Q48547464-2B663676-0DE6-4F4F-A0A8-53617514D4C2Q51065265-9F063D69-B7A8-420E-A5F3-1FB67C681C75Q52870398-FE9D67F9-E81E-4449-8450-096659B0EBE0Q53396745-2CDEA044-2A61-43F6-9763-819BF784E725Q57300558-FFFCF80F-2AA3-44C1-A2D8-980D908815DDQ58693321-6D6F70BA-C72B-41EA-80FF-EC5CD1CB9FA3Q58728300-A038976C-3D0C-4C1A-86AE-8749ACD9CCE4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cerebrospinal fluid biomarkers for Alzheimer's disease.
@en
Cerebrospinal fluid biomarkers for Alzheimer's disease.
@nl
type
label
Cerebrospinal fluid biomarkers for Alzheimer's disease.
@en
Cerebrospinal fluid biomarkers for Alzheimer's disease.
@nl
prefLabel
Cerebrospinal fluid biomarkers for Alzheimer's disease.
@en
Cerebrospinal fluid biomarkers for Alzheimer's disease.
@nl
P921
P356
P1476
Cerebrospinal fluid biomarkers for Alzheimer's disease.
@en
P304
P356
10.3233/JAD-2009-1177
P577
2009-01-01T00:00:00Z